Angiotensin II receptor blockade in diabetic nephropathy [5]

American Journal of Hypertension

Volumn 16, Issue 1, 2003, Pages 100-101

  Lewis, Edmund J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CREATININE; LOSARTAN; RAMIPRIL;

CREATININE CLEARANCE; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; HYPERTENSION, RENAL; LOSARTAN; RECEPTORS, ANGIOTENSIN;

EID: 0037233143     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03152-7     Document Type: Letter

References (7)

1. Ruddy MC: Angiotensin II receptor blockade in diabetic nephropathy. Am J Hypertens 2002;15:468-471.
2. Lewis EJ, Hunsicker L, Clarke W, Berl T, Pohl M, Lewis J, Ritz E, Atkins R, Rohde R, Raz I, for The Collaborative Study Group: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860.
3. Brenner B, Cooper M, de Zeeuw D, Keane W, Mitch W, Parving H, Remuzzi G, Snapinn S, Zhang Z, Shahinfar S, for the RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869.
4. Lewis J, Berl T, Bain RP, Rohde RD, Lewis EJ, and The Collaborative Study Group: Effect of intensive blood pressure control on the course of type I diabetic nephropathy. Am J Kidney Dis 1999;34:809-817.
5. Schwartz MM, Lewis EJ, Leonard-Martin T, Lewis J, Batlle D, and the Collaborative Study Group: Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. Nephrol Dial Transplant 1998;13:2547-2552.
6. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M: The reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75.
7. Parving H, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P, for the Irbesartan in patients with type 2 Diabetes and Microalbuminuria Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878.